Dr. Lawenda advocates for universal genetic testing for all cancer patients, arguing that current guidelines miss a significant number of individuals with actionable mutations. He highlights the substantial benefits of identifying these mutations, including personalized treatment options and early risk assessment for patients and their families. The argument emphasizes the improved care and equity achieved through universal testing, despite the relatively low cost, while acknowledging the need for discussion with healthcare professionals to weigh the pros and cons. Studies cited show a considerable portion of patients outside traditional testing criteria still harbor significant mutations. The ultimate goal is to save lives and empower patients through informed decision-making.